Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2017 / Cilt: 51 - Sayı: 3

Metabolic Abnormalities in Children with Urinary Stone Disease and The Influence of Gender

Üriner sistem taşı olan çocuklarda metabolik bozukluklar ve cinsiyetin etkisi

Pages
218–224
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Female gender may be accepted as a predisposing factor for metabolic abnormality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Urinary stone disease is associated with age, gender, diet, climate, and genetic causes.
📊
Key Findings & Data:We aimed to evaluate epidemiologic and metabolic factors in children with urolithiasis.Material and Methods: A total of 89 patients (46 girls), aged between 0 and 18 years with diagnosis of urolithiasis, microlithiasis and a history of urolithiasis were recruited in this retrospective study.
💡
Conclusion & Impact:Female gender may be accepted as a predisposing factor for metabolic abnormality.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Urinary stone disease is associated with age, gender, diet, climate, and genetic causes. Infections, anatomic and metabolic abnormalities can lead to stone formation. We aimed to evaluate epidemiologic and metabolic factors in children with urolithiasis.Material and Methods: A total of 89 patients (46 girls), aged between 0 and 18 years with diagnosis of urolithiasis, microlithiasis and a history of urolithiasis were recruited in this retrospective study. Medical records were assessed for current age, gender, age at diagnosis, presenting symptoms, family history, physical findings, medications, results of laboratory tests (including blood urea nitrogen, serum creatinine, electrolytes, blood gases, urinalysis:urinary calcium, uric acid, oxalate, cystine, citrate, magnesium and creatinine levels) and radiological findings. Results: The mean age was 6.20±5.27 (range, 0.2-18.2 years). Stones were mostly located in the kidneys (n=52, 58.4%). Microlithiasis, urolithiasis and urolithiasis history were defined in 22 (24.7%), 64 (71.9%), and 3 (3.4%) patients, respectively. Anatomic abnormalities were determined in 17.9% of the patients. Of all patients, 31 (34.8%) had metabolic abnormalities in their urinary analyses. While 26 patients (29.2%) had one metabolic abnormality, five (5.6%) patients had more than one. Metabolic abnormalities were two times more in girls than in boys (p=0.027). The most common metabolic disorder detected was hypocitraturia (n=16, 17.9%), followed by hyperoxaluria (n=8, 8.9%), hypercalciuria (n=6, 6.7%), and hyperuricosuria (n=6, 6.7%). Conclusions: Metabolic abnormalities were detected frequently in children with urinary stone disease. Hypocitraturia was the most common metabolic abnormality. Detailed evaluation is needed to manage patients with urolithiasis. Female gender may be accepted as a predisposing factor for metabolic abnormality.

Özet

Amaç: Üriner sistemde taş varlığı; yaş, cinsiyet, diyet, iklim ve genetik nedenlerle ilişkilidir. Enfeksiyonlar, anatomik ve metabolik bozukluklar taş oluşuma eğilim yaratan nedenlerdir. Bu çalışmada üriner sistem taşı olan çocuklarda epidemiyolojik ve metabolik faktörlerin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntemler: Retrospektif olan bu çalışmada, ürolitiazis, mikrolitiazis ve ürolitiazis hikayesi olan 0-18 yaş aralığındaki 89 (46 kız) hastanın dosyası geriye dönük şekilde incelendi. Güncel yaş, cinsiyet, tanı yaşı, başvuru semptomları, ailede taş hikayesi, fizik muayene bulguları, kullandıkları ilaçlar, laboratuvar tetkikleri (kan üre nitrojeni, serum kreatinin, elektrolit, kan gazları; idrarda kalsiyum, ürik asit, okzalat, sistin, sitrat, magnezyum ve kreatinin düzeyleri değerlendirildi) ve radyolojik bulgular kaydedildi. Bulgular: Yaş ortalaması 6.20±5.27 (minimum-maksimum, 0.2-18.2) yıl idi. Taşlar en sık böbrekte yerleşmekteydi (n=52, %58.4). Yirmi iki hasta (%24.7) mikrolitiazis, 64 hasta (%71.9) ürolitiazis ve üç hasta (%3.4) ürolitiazis hikayesi olan grupta idi. Anatomik sorunlar %17.9 hastada saptandı. Tüm hastaların 31'inde (%34.8) idrar analizlerinde metabolik bozukluk saptandı. Yirmi altı (%29.2) hastada tek metabolik bozukluk saptanırken, birden fazla metabolik bozukluk beş (%5.6) hastada tespit edildi. Kızlarda metabolik bozukluk erkeklerden iki kat fazla idi (p=0.027). En sık metabolik bozukluk hipositratüri (n=16, %17.9) ve sonrasında hiperokzalüri (n=8, %8.9), hiperkalsiüri (n=6, %6.7) ve hiperürikozüri (n=6, %6.7) olarak tespit edildi. Sonuçlar: Üriner sistem taşı olan çocuklarda metabolik bozukluklar sık saptandı. Hipositratüri en sık saptanan bozukluklardan olup hasta yönetimi için kapsamlı değerlendirme gereklidir. Kız cinsiyet metabolik bozukluk için yatkınlık oluşturan bir faktör olarak kabul edilebilir.

🔖

Cite This Article

TAŞDEMİR, M. (2017). Metabolic Abnormalities in Children with Urinary Stone Disease and The Influence of Gender. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 51 - Sayı: 3, 218–224. https://ajindex.com/articles/363750

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Pearle MS, Antonelli JA, Lotan Y. Urinary Lithiasis: Etiology, Epidemology, and Pathogenesis. In: Wein AJ (ed) CampbellWalsh Urology, 17th ed. Philadelphia: Elsevier; 2016. p.1170-99
  2. Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Hussain M, Zafar MN, et al. Pediatric urolithiasis: developing nation perspectives. J Urol 2002; 168: 1522-5. [CrossRef] 3. Akinci M, Esen T, Tellaloglu S. Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol 1991; 20: 200-3
  3. Lieske JC, Toback FG. Renal cell-urinary crystal interactions. Curr Opin Nephrol Hypertens 2000; 9: 349-55. [CrossRef] 5. Alpay H, Ozen A, Gokce I, Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 2009; 24: 2203-9. [CrossRef] 6. Bastug F, Dusunsel R. Pediatric urolithiasis: causative factors, diagnosis and medical management. Nat Rev Urol 2012; 9: 138- 46. [CrossRef] 7. Bilge I, Yilmaz A, Kayiran SM, Emre S, Kadioglu A, Yekeler E, et al. Clinical importance of renal calyceal microlithiasis in children. Pediatr Int 2013; 55: 731-6. [CrossRef] 8. Celiksoy MH, Yilmaz A, Aydogan G, Kiyak A, Topal E, Sander S. Metabolic disorders in Turkish children with urolithiasis. Urology 2015; 85: 909-13. [CrossRef] 9. Ece A, Ozdemir E, Gurkan F, Dokucu AI, Akdeniz O. Characteristics of pediatric urolithiasis in south-east Anatolia. Int J Urol 2000; 7: 330-4. [CrossRef] 10. Elmaci AM, Ece A, Akin F. Pediatric urolithiasis: metabolic risk factors and follow-up results in a Turkish region with endemic stone disease. Urolithiasis 2014; 42: 421-6. [CrossRef] 11. Kok DJ, Papapoulos SE, Bijvoet OL. Excessive crystal agglomeration with low citrate excretion in recurrent stoneformers. Lancet 1986; 1: 1056-8. [CrossRef] 12. Hoppe B, Leuman E, Milliner DS. Urolithiasis and nephrocalcinosis in childhood. In: Geary DF (ed). Comprehensive Pediatric Nephrology. 1st ed. Philadelphia: Mosby; 2008. p.499-526. [CrossRef] 13. Cystine Quantitative, Urine. Available from: http://ltd.aruplab. com/Tests/Pub/0081106 14. Matos V, Van Melle G, Boulat O, Markert M, Bachmann C, Guignard JP. Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr 1997; 131: 252-7. [CrossRef] 15. Alpay H, Gokce I, Ozen A, Biyikli N. Urinary stone disease in the first year of life: is it dangerous? Pediatr Surg Int 2013; 29: 311-6. [CrossRef] 16. Hoppe B, Kemper MJ. Diagnostic examination of the child with urolithiasis